ResultsIQ

ResultsIQ › Latest results › TAKE Limited

TAKE Limited Q2 FY27 results press release summary

NSE: TAKE · BSE: 532890

Results press release of 13 Nov 2026, summarised by AI from the filing.

Q2 FY27 consolidated Net Profit ₹22.12 Million, 108.17% quarter-on-quarter growth over ₹10.63 Million in Q1 FY27.

Key takeaways

  1. Q2 profit Q2 FY27 consolidated Net Profit ₹22.12 Million, 108.17% quarter-on-quarter growth over ₹10.63 Million in Q1 FY27.
  2. Standalone swing Standalone H1 FY27 Net Profit ₹31.89 Million, compared with a loss of ₹27.83 Million in the same six months of the previous year.
  3. TAKE.Health Launched an intelligent digital health companion that combines lifestyle and medical data into personalized, actionable health insights.
  4. Execution risk The company says its next phase depends on combining financial recovery with successful execution of its evolving business strategy.

Original filing on BSE

TAKE Limited Q2 FY27 results

As filed: Revenue ₹29.4 cr, EBITDA ₹1.8 cr, PAT ₹2.2 cr, EBITDA margin 6.0%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹29.4 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹30.4 cr, EBITDA −₹0.3 cr, PAT ₹1.1 cr, EBITDA margin -0.9%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹30.4 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: −27.8% in 30 days (Nifty 500: −3.1%).
  • Q4 FY26: Revenue ₹54.2 cr, EBITDA −₹0.8 cr, PAT ₹4.4 cr, EBITDA margin -1.5%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹54.2 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +12.1% in 30 days (Nifty 500: +2.5%).
  • Q3 FY26: Revenue ₹0.0 cr, EBITDA −₹0.4 cr, PAT ₹1.1 cr. Not scored. Too small to score: quarter revenue ₹0.0 cr is below the ₹20.0 cr minimum. On a base this small, percentage changes say little. Share price after the results: −17.1% in 30 days (Nifty 500: −7.8%).
  • Q2 FY26: Revenue ₹0.0 cr, EBITDA ₹0.0 cr, PAT ₹6.0 cr. Not scored. Too small to score: quarter revenue ₹0.0 cr is below the ₹20.0 cr minimum. On a base this small, percentage changes say little. Share price after the results: +23.8% in 30 days (Nifty 500: +1.1%).
  • Q1 FY26: Revenue ₹0.0 cr, EBITDA −₹1.0 cr, PAT −₹1.0 cr. Not scored. Too small to score: quarter revenue ₹0.0 cr is below the ₹20.0 cr minimum. On a base this small, percentage changes say little. Share price after the results: −14.9% in 30 days (Nifty 500: −3.8%).
  • Q4 FY25: Revenue ₹0.0 cr, EBITDA −₹2.0 cr, PAT −₹5.0 cr. Not scored. Too small to score: quarter revenue ₹0.0 cr is below the ₹20.0 cr minimum. On a base this small, percentage changes say little. Share price after the results: −1.8% in 28 days (Nifty 500: +3.6%).
  • Q3 FY25: Revenue ₹0.0 cr, EBITDA −₹3.0 cr, PAT ₹48.0 cr. Not scored. Too small to score: quarter revenue ₹0.0 cr is below the ₹20.0 cr minimum. On a base this small, percentage changes say little.

Past price moves after results do not indicate future moves. Not a recommendation.

TAKE Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.